Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome

Endocrine Journal

Volumn 58, Issue 9, 2011, Pages 789-799

  Chandran, Dinu S ^a   Jaryal, Ashok Kumar ^a   Jyotsna, Viveka P ^a   Deepak, Kishore Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cushing's syndrome; Endothelial function; Photoplethysmography; Vascular reactivity

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPEREMIA; MALE; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PULSE WAVE; STANDARD;

ADOLESCENT; ADULT; CUSHING SYNDROME; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROCORTISONE; HYPEREMIA; MALE; PHOTOPLETHYSMOGRAPHY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 80053898763     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0030     Document Type: Article

References (37)

1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing's syndrome. Lancet 367: 1605-1617.
2. Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing's syndrome. Lancet 357: 783-791.
3. Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 34: 327-339.
4. Whitworth JA, Williamson PM, Mangos G, Kelly JJ (2005) Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 1: 291-299.
5. Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 40: 479-484.
6. Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing's syndrome. Am J Med 13: 597-614.
7. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, et al. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84: 2664-2672.
8. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, et al. (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88: 2527-2533.
9. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ (1977) The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 26: 151-162.
10. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, et al. (2003) Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92: 81-87.
11. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA (2000) Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens 13: 1155-1160.
12. Rizzoni D, Porteri E, De Ciuceis C, Rodella LF, Paiardi S, Rizzardi N, et al. (2009) Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. J Clin Endocrinol Metab 94: 5010-5018.
13. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, et al. (2007) Impairment of flowmediated vasodilatation of brachial artery in patients with Cushing's Syndrome. Endocrine 31: 300-304.
14. Prázný M, Jezková J, Horová E, Lazárová V, Hána V, Kvasnicka J, et al. (2008) Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension. Physiol Res 57: 13-22.
15. Akaza I, Yoshimoto T, Tsuchiya K, Hirata Y (2010) Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome. Endocr J 57: 245-252.
16. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, et al. (2003) Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146: 168-174.
17. Zahedi E, Jaafar R, Ali MAM, Mohamed AL, Maskon O (2008) Finger photoplethysmogram pulse amplitude changes induced by flow-mediated dilation. Physiol Meas 29: 625-637.
18. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P (2006) Role of nitric oxide in the reg ulation of digital pulse volume amplitude in humans. J Appl Physiol 101: 545-548.
19. Allen J (2007) Photoplethysmography and its application in clinical physiological measurement. Physiol Meas 28: R1-39.
20. Shelley KH (2007) Photoplethysmography: beyond the calculation of arterial oxygen saturation and heart rate. Anesth Analg 105: S31-36.
21. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295.
22. Selvaraj N, Jaryal AK, Santhosh J, Anand S, Deepak KK (2009) Monitoring of reactive hyperemia using photoplethysmographic pulse amplitude and transit time. J Clin Monit Comput 23: 315-322.
23. Conti M, Morand PC, Levillain P, Lemonnier A (1991) Improved fluorometric determination of malonaldehyde. Clin Chem 37: 1273-1275.
24. Knight JA, Pieper RK, McClellan L (1988) Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 34: 2433-2438.
25. Liu TZ, Chin N, Kiser MD, Bigler WN (1982) Specific spectrophotometry of ascorbic acid in serum or plasma by use of ascorbate oxidase. Clin Chem 28: 2225-2228.
26. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974.
27. Henry RMA, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, et al. (2004) Type 2 diabetes is associated with impaired endothelium-dependent, flowmediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis 174: 49-56.
28. Carlsson I, Sollevi A, Wennmalm A (1987) The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J Physiol 389: 147-161.
29. Imms FJ, Lee WS, Ludlow PG (1988) Reactive hyperaemia in the human forearm. Q J Exp Physiol 73: 203-215.
30. Koller A, Bagi Z (2002) On the role of mechanosensitive mechanisms eliciting reactive hyperemia. Am J Physiol Heart Circ Physiol 283: H2250-2259.
31. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265.
32. Kamran H, Salciccioli L, Ko EH, Qureshi G, Kazmi H, Kassotis J, et al. (2010) Effect of reactive hyperemia on carotid-radial pulse wave velocity in hypertensive participants and direct comparison with flow-mediated dilation: a pilot study. Angiology 61: 100-106.
33. Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH (2006) Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J 27: 302-309.
34. Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267.
35. Maritim AC, Sanders RA, Watkins JB 3rd (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-38.
36. Wallerath T, Witte K, Schäfer SC, Schwarz PM, Prellwitz W, Wohlfart P, et al. (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A 96: 13357-13362.
37. Johns DG, Dorrance AM, Tramontini NL, Webb RC (2001) Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med (Maywood) 226: 27-31.